0000000000156853

AUTHOR

J. Baumgart

showing 12 related works from this author

Extended resection of intrahepatic cholangiocarcinoma: A retrospective single-center cohort study

2019

Abstract Background For complete removal of intrahepatic cholangiocarcinoma (ICC), extended resection is often necessary. Information on the influence of visceral or vascular extension, extended resection, or postoperative morbidity on survival is scarce. The aim of this study was to show the impact of an aggressive surgical attitude on morbidity, mortality, and long-term outcome. Materials and methods All explorations at a high volume tertiary center between January 2008 and June 2018 with histological proof of ICC were included in this retrospective cohort study. The primary outcome was the extent of resection, secondary outcomes were postoperative morbidity, and their influence on overal…

Malemedicine.medical_specialtySingle CenterResectionCholangiocarcinomaPrimary outcomeOverall survivalHepatectomyHumansMedicineIn patientPostoperative PeriodIntrahepatic CholangiocarcinomaAgedRetrospective Studiesbusiness.industryLiver NeoplasmsRetrospective cohort studyGeneral MedicineMiddle AgedSurvival AnalysisSurgeryBile Ducts IntrahepaticTreatment OutcomeBile Duct NeoplasmsFemaleSurgeryMorbiditybusinessCohort studyInternational Journal of Surgery
researchProduct

Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic Cholangiocarcinoma

2021

(1) Background: Intrahepatic cholangiocarcinoma (ICC) is a rare malignancy. Besides tumor, nodal, and metastatic status, the UICC TNM classification describes further parameters such as lymphangio- (L0/L1), vascular (V0/V1/V2), and perineural invasion (Pn0/Pn1). The aim of this study was to analyze the influence of these parameters on recurrence and survival. (2) Methods: All surgical explorations for patients with ICC between January 2008 and June 2018 were collected and further analyzed in our institutional database. Statistical analyses focused on perineural, lymphangio-, and vascular invasion examined histologically and their influence on tumor recurrence and survival. (3) Results: Of 2…

medicine.medical_specialtyPerineural invasionMalignancyGastroenterologysurvivalArticleResectionVascular invasion03 medical and health sciences0302 clinical medicineintrahepatic cholangiocarcinomaInternal medicineStatistical analysesmedicineOverall survivalvascular invasionliver surgeryIntrahepatic Cholangiocarcinomabusiness.industryRlymphangioinvasionGeneral Medicineperineural invasionmedicine.diseaseTumor recurrence030220 oncology & carcinogenesisMedicine030211 gastroenterology & hepatologybusinessJournal of Clinical Medicine
researchProduct

Another Small Step Forward in ALPPS

2020

Information retrievalText miningPortal Veinbusiness.industryHepatectomyHumansMedicineSurgerybusinessLigationAnnals of Surgery
researchProduct

Erweiterte Hemihepatektomie rechts mit Hepatikusgabelresektion und Rekonstruktion der Pfortadergabel und der linken Lebervene bei cholangiozellulärem…

2018

ZusammenfassungDie vollständige Resektion gilt bei Patienten mit cholangiozellulärem Karzinom als Therapie der Wahl. Aufgrund der Tumorausdehnung sind hierbei Resektion und Rekonstruktion vaskulärer Strukturen häufig erforderlich. Dreidimensionale Rekonstruktionen der Schnittbildgebung können in diesen Fällen hilfreich für die Resektionsplanung sein. Das vorliegende Video zeigt eine erweiterte Hemihepatektomie rechts mit Hepatikusgabelresektion mit Resektion und Rekonstruktion der Pfortadergabel und einer von 2 linken Lebervenen bei einem intrahepatischen cholangiozellulären Karzinom.

Gynecology03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industry030220 oncology & carcinogenesisMedicineSurgery030230 surgerybusinessZentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie
researchProduct

Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk Assessment

2021

Several scoring systems have been devised to objectively predict survival for patients with intrahepatic cholangiocellular carcinoma (ICC) and support treatment stratification, but they have failed external validation. The aim of the present study was to improve prognostication using an artificial intelligence-based approach. We retrospectively identified 417 patients with ICC who were referred to our tertiary care center between 1997 and 2018. Of these, 293 met the inclusion criteria. Established risk factors served as input nodes for an artificial neural network (ANN). We compared the performance of the trained model to the most widely used conventional scoring system, the Fudan score. Pr…

Scoring systemTertiary careArticle03 medical and health sciences0302 clinical medicineintrahepatic cholangiocarcinomaMedicinesurvival predictionIntrahepatic Cholangiocarcinomarisk scoringTraining setFudan scoreArtificial neural networkbusiness.industryRExternal validationGeneral Medicineartificial intelligencemachine learningCholangiocellular carcinoma030220 oncology & carcinogenesisMedicine030211 gastroenterology & hepatologyArtificial intelligencebusinessRisk assessmentartificial neural networkJournal of Clinical Medicine
researchProduct

Intrahepatic cholangiocarcinoma: Introducing the preoperative prediction score based on preoperative imaging.

2020

Intrahepatic cholangiocarcinoma (ICC) still has a poor long-term outcome, even after complete resection. We investigated different parameters gathered in preoperative imaging and analyzed their influence on resectability, recurrence, and survival.All patients who underwent exploration due to ICC between January 2008 and June 2018 were analyzed retrospectively. Kaplan-Meier model, log-rank test and Cox regression were used.Out of 184 patients, 135 (73.4%) underwent curative intended resection. Median overall survival (OS) was 22.2 months with a consecutive 1-, 3- and 5-year OS of 73%, 29%, and 17%. Median recurrence-free survival (RFS) was 9.3 months with a consecutive 1-, 3- and 5-year RFS …

medicine.medical_specialtyPrediction scoreUnivariate analysisHepatologyTumor sizeProportional hazards modelbusiness.industryGastroenterology030230 surgeryPrognosisComplete resectionCholangiocarcinoma03 medical and health sciences0302 clinical medicineRisk groupsBile Ducts IntrahepaticBile Duct NeoplasmsmedicineHumans030211 gastroenterology & hepatologyRadiologybusinessIntrahepatic CholangiocarcinomaPreoperative imagingRetrospective StudiesHepatobiliarypancreatic diseases international : HBPD INT
researchProduct

The role of hepatic resection for metastases from gastric cancer: When is it worthwhile? a single center experience

2016

medicine.medical_specialtyHepatologybusiness.industryHepatic resectionGastroenterologyMedicineCancerSingle Centerbusinessmedicine.diseaseSurgeryHPB
researchProduct

Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion.

2021

Non-cirrhotic portal vein thrombosis (PVT) in patients with antiphospholipid syndrome (APS) is a rare complication, and the management has to be determined individually based on the extent and severity of the presentation. We report on a 37-year-old male patient with non-cirrhotic chronic PVT related to a severe thrombophilia, comprising APS, antithrombin-, factor V- and factor X-deficiency. Three years after the initial diagnosis of non-cirrhotic PVT, the patient presented with severe hemorrhagic shock related to acute bleeding from esophageal varices, requiring an emergency transjugular intrahepatic portosystemic stent shunt (TIPSS). TIPSS was revised after a recurrent bleeding episode du…

AdultMalemedicine.medical_specialtyPortal venous pressuremedicine.medical_treatment030204 cardiovascular system & hematologyThrombophiliaEsophageal and Gastric Varices03 medical and health sciences0302 clinical medicineEsophageal varicesHypertension PortalmedicineHumansThrombophiliaEmbolizationPatient Care TeamVenous Thrombosisbusiness.industryPortal VeinGastroenterologymedicine.diseaseThrombosisSurgeryPortal vein thrombosisPortal hypertension030211 gastroenterology & hepatologyStentsPortasystemic Shunt Transjugular IntrahepaticbusinessVaricesGastrointestinal HemorrhageZeitschrift fur Gastroenterologie
researchProduct

Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Registry: What Have We Learned?

2020

In 2007, the first associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure was performed in Regensburg, Germany. ALPPS is a variation of two-stage hepatectomy to induce rapid liver hypertrophy allowing the removal of large tumors otherwise considered irresectable due to a too small future liver remnant. In 2012, the international ALPPS registry was created, and it now contains more than 1,000 cases. During the past years, improved patient selection and refinements in operative techniques, in particular, less invasive approaches such as Partial ALPPS, Tourniquet ALPPS, Ablation-assisted ALPPS, Hybrid ALPPS or Laparoscopic or Robotic approaches, have resu…

medicine.medical_specialtymedicine.medical_treatmentLess invasivePortal vein ligationReviewResection03 medical and health sciences0302 clinical medicineCarcinomaHepatectomyHumansMedicineRegistriesPerihilar CholangiocarcinomaRandomized Controlled Trials as TopicTwo-stage hepatectomyALPPS registryHepatologyPortal Veinbusiness.industryCarcinoma hepatocellularLiver NeoplasmsGastroenterologymedicine.diseaseSurgeryTreatment OutcomeBile Duct NeoplasmsLiver030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyALPPSOutcome dataHepatectomyPerihilar cholangiocarcinomabusinessGut and Liver
researchProduct

Liver Resection for Intrahepatic Cholangiocarcinoma—Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year P…

2021

Background: Intrahepatic cholangiocarcinoma (iCCA) accounts for about 10% of primary liver cancer. Surgery is the only potentially curative treatment. We report on our current series of 229 consecutive hepatic resections for iCCA, which is one of the largest Western single-center series published so far. Methods: Between January 2008 to December 2020, a total of 286 patients underwent 307 surgical explorations for intended liver resection of iCCA at our department. Data were analyzed with regard to (1) preoperative treatment of tumor, (2) operative details, (3) perioperative morbidity and mortality, (4) histopathology, (5) outcome measured by tumor recurrence, treatment of recurrence and su…

medicine.medical_specialtyProportional hazards modelbusiness.industrymedicine.medical_treatmentRGeneral MedicinePerioperativeSingle Centersurvivalrepeated liver resectionArticleSurgeryintrahepatic cholangiocarcinomaliver resectionmedicineMedicineT-stageHistopathologyHepatectomyStage (cooking)businesscholangiocarcinomaIntrahepatic CholangiocarcinomaJournal of Clinical Medicine
researchProduct

Resection of intrahepatic cholangiocarcinoma

2016

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicineRadiologybusinessIntrahepatic CholangiocarcinomaResectionHPB
researchProduct

Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive …

2018

Intrahepatic cholangiocarcinoma (ICC) is a rare malignancy, and therefore large unicenter series on the surgical outcome are rare in the literature, and prognostic factors for overall survival in the literature vary widely.All patients who underwent surgery for ICC were prospectively recorded. The type of resection, operative details, histological results, morbidity, mortality, overall and recurrence-free survivals as well as prognostic factors were assessed. Prognostic factors were examined by univariate and multivariate analyses. P-values0.05 were considered significant.Between January 2008 and December 2015, 102 patients underwent a resection with curative intent and were included in thi…

AdultMaleCurative resectionmedicine.medical_specialtyMultivariate analysis030230 surgeryMalignancySingle CenterDisease-Free SurvivalCholangiocarcinoma03 medical and health sciences0302 clinical medicinemedicineHepatectomyHumansNeoplasm InvasivenessIntrahepatic CholangiocarcinomaAgedRetrospective StudiesAged 80 and overAnalysis of VarianceUnivariate analysisbusiness.industryRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurgeryVisceraBile Ducts IntrahepaticTreatment OutcomeBile Duct Neoplasms030220 oncology & carcinogenesisFemaleSurgerybusinessInfiltration (medical)International Journal of Surgery
researchProduct